← Back
$MLYS All transactions

Mineralys Therapeutics, Inc.

▲ BUY
8 / 10

Conviction

$ Value

$15.0M

Shares

588,235

Price

$26

Filed

Sep 8

Why this score? (8/10)
  • Open market buy (+3)
  • Trade value >= $5.0M (+3)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

AKKARAJU SRINIVAS

Title

CIK

0001253170

Roles

Director

Transaction Details

Transaction Date

2025-09-04

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

588,235

Footnotes

Securities are directly held by Samsara Opportunity Fund, L.P. ("Samsara Opp LP"). Samsara Opportunity Fund GP, LLC ("Samsara Opp GP") is the general partner of Samsara Opp LP and may be deemed to beneficially own the securities held by Samsara Opp LP. The Reporting Person has voting and investment power over the shares held by Samsara Opp LP and, accordingly, may be deemed to beneficially own the shares held by Samsara Opp LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein. | Securities are directly held by Samsara BioCapital L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.

Filing Info

Accession No.

0001415889-25-023919

Form Type

4

Issuer CIK

0001933414

AKKARAJU SRINIVAS's History

Date Ticker Type Value
2026-01-09 ALMS $10.0M
2025-12-22 KLRS A $15.0M
2025-12-12 SRRK X $7.8M
2025-12-12 SRRK X $0
2025-12-05 ALMS $581K
2025-12-05 ALMS $701K
2025-12-05 ALMS $551K
2025-12-04 ALMS $540K
2025-12-03 ALMS $775K
2025-12-02 ALMS $725K

Other Insiders at MLYS (90d)

Insider Bought Sold Last
RA CAPITAL MANAGEMENT, L.P. $8.8M 2026-03-30
Congleton Jon
Chief Executive Officer
$2.4M 2026-04-13
Rodman David Malcom
Chief Medical Officer
$621K 2026-04-17
Karydas Daphne $75K 2026-03-31